Default company panoramic image
Logo

Neural Analytics

We offer a noninvasive solution for measuring intracranial pressure that currently requires a neurosurgeon to drill a hole into the skull.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Los Angeles, CA, USA
  • Currency USD
  • Founded January 2013
  • Employees 3
  • Website neuralanalytics.com

Company Summary

Intracranial pressure (ICP), the pressure inside the skull, is a key physiologic metric that is used to diagnose numerous neurologic conditions including those stemming from traumatic brain injury (TBI). At Neural Analytics, we are developing a noninvasive method for measuring ICP using a portable ultrasound technology. Initial results of approximately 100 of these patients showed an accuracy of 92% for detection of IH.

Team

  • Default avatar
    Leo Petrossian
    CEO

    Dr. Leo Petrossian is a co-founder of the venture and will be stepping into the role of Chief Executive Officer. Dr. Petrossian, a repeat entrepreneur, will oversee the business aspects of the venture. After earning his doctorate in biomolecular nanotechnology, Dr. Petrossian, a MBA candidate at the UCLA Anderson, spent the following five years developing novel nanotechnologies within the biotech space.

  • Default avatar
    Daniel Hanchey
    VP of Business Development

    Mr. Dan Hanchey is a co-founder of the venture and will be stepping into the role of Vice President of Business Development. Mr. Hanchey is a third-year MBA candidate at UCLA Anderson who has 16 years of software development experience. As a senior software architect, Mr. Hanchey led a team of 12 software developers responsible for a market leading CAD/CAM application.

  • Default avatar
    Robert Hamilton
    VP of Research

    Mr. Robert Hamilton is a co-founder of the venture and will be stepping into the role of Vice President of Research and Development. A fifth-year PhD candidate in Biomedical Engineering at UCLA, Mr. Hamilton has spent the past four years refining and developing this technology within an academic setting and has several publications and presentations on the topics of ICP, and both acute and chronic brain injuries.

Advisors

  • Default avatar
    Heather McCormick, CREDO
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    N/A
    Unconfirmed